- EU has given approval to new improving vaccines for the mutant covid strains.
- This will fast track new vaccines variants from already available covid vaccines
- The move comes amidst the member state’s displeasure of approval delay.
- EU has ruled out closing borders to stem infection.
According to a US News report, the European Union will fast track approvals of coronavirus vaccines adapted to combat mutations, the bloc’s Health Commissioner Stella Kyriakides said in a newspaper interview on Sunday.
Fast Tracking Vaccine Approval
“We have now decided that a vaccine that has been improved by the manufacturer on the basis of the previous vaccine to combat new mutations no longer has to go through the entire approval process,” she told Bavaria’s Augsburger Allgemeine.
“So it will be faster to have suitable vaccines available without compromising on safety.”
EU Lagging in Approving Vaccines
The European Commission has come under fire from EU member states over delays to deliveries of vaccines which has seen the bloc lag behind countries such as Britain, a former member, and the United States.
Kyriakides is a member of a new task force, led by Industry Commissioner Thierry Breton, to eliminate bottlenecks in production plants and adjust output to new variants.
Vaccinations To Pickup
While vaccinations in the first quarter of 2021 have started slowly, the second quarter would see a pick-up and by the end of September the EU expects to have received sufficient doses from licensed producers to cover over 70% of its population, Kyriakides said.
Closing Borders Not A Viable Solution
She also reiterated the Commission’s view that closing borders were not an effective weapon against infections.
“I think it is wrong for us to return to a Europe with closed borders, as in March 2020,” she said.
Germany will enforce entry bans on travelers from the Czech Republic and Austria’s Tyrol region from Sunday to prevent the spread of new variants.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: Business Today
